免疫学：一种宽容的方法。 - Suppr

Suppr

超能文献

Immunology: A tolerant approach.

作者信息

Garber Ken

出版信息

Nature. 2014 Mar 27;507(7493):418-20. doi: 10.1038/507418a.

DOI:10.1038/507418a

PMID:24670744

Abstract

摘要

相似文献

Immunology: A tolerant approach.免疫学：一种宽容的方法。

Nature. 2014 Mar 27;507(7493):418-20. doi: 10.1038/507418a.

The battle to tame autoimmunity.驯服自身免疫的战斗。

Nature. 2018 Mar 8;555(7695):S8-S9. doi: 10.1038/d41586-018-02476-2.

[Current therapy of multiple sclerosis: "T-cell vaccination"].

Nervenarzt. 1994 Jun;65(6):424-5.

Parameters influencing antigen-specific immunotherapy for Type 1 diabetes.影响1型糖尿病抗原特异性免疫治疗的参数。

Immunol Res. 2008;42(1-3):246-58. doi: 10.1007/s12026-008-8090-5.

Synthetic approaches to vaccines for infectious and autoimmune diseases.

Vaccine. 1992;10(14):991-9. doi: 10.1016/0264-410x(92)90107-u.

Nanoparticles for the induction of antigen-specific Tregs.

Immunotherapy. 2013 May;5(5):437-40. doi: 10.2217/imt.13.25.

Organ-specific autoimmune disease: a deficiency of tolerogenic stimulation.器官特异性自身免疫性疾病：耐受性刺激的缺乏。

J Exp Med. 2001 Sep 3;194(5):F31-6. doi: 10.1084/jem.194.5.f31.

Immunotherapy. Wielding worms at asthma and autoimmunity.免疫疗法。利用蠕虫治疗哮喘和自身免疫性疾病。

Science. 2004 Jul 9;305(5681):171. doi: 10.1126/science.305.5681.171.

Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.用于重建1型糖尿病患者T细胞耐受性的基因疫苗接种

Hum Vaccin. 2011 Jan 1;7(1):27-36. doi: 10.4161/hv.7.1.12848.

Gene therapy for immunological tolerance: using 'transgenic' B cells to treat inhibitor formation.基因治疗免疫耐受：利用“转基因”B 细胞治疗抑制剂形成。

Haemophilia. 2010 May;16(102):89-94. doi: 10.1111/j.1365-2516.2010.02203.x.

引用本文的文献

An Overview of Peptide-Based Molecules as Potential Drug Candidates for Multiple Sclerosis.肽类分子作为多发性硬化症潜在药物的研究进展。

Molecules. 2021 Aug 28;26(17):5227. doi: 10.3390/molecules26175227.

Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis.纳米颗粒介导的自身抗原肽靶向共递呈肝窦内皮细胞可预防 CD8 T 细胞驱动的自身免疫性胆管炎。

Immunology. 2021 Apr;162(4):452-463. doi: 10.1111/imm.13298. Epub 2021 Jan 7.

The Effects of Alternate-Day Corticosteroids in Autoimmune Disease Patients.隔日使用皮质类固醇对自身免疫性疾病患者的影响。

Autoimmune Dis. 2020 May 18;2020:8719284. doi: 10.1155/2020/8719284. eCollection 2020.

Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective.诱导耐受的细胞疗法的未来方向——AFACTT 的观点。

Front Immunol. 2019 Feb 22;10:181. doi: 10.3389/fimmu.2019.00181. eCollection 2019.

ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs.ATX-MS-1467通过诱导分泌白细胞介素-10的诱导性调节性T细胞，使（DR2×Ob1）F1小鼠对髓鞘碱性蛋白产生长期耐受性。

Neurol Ther. 2018 Jun;7(1):103-128. doi: 10.1007/s40120-018-0094-z. Epub 2018 Mar 14.

A Sensitive Method for Detecting Peptide-specific CD4 T Cell Responses in Peripheral Blood from Patients with Myasthenia Gravis.一种检测重症肌无力患者外周血中肽特异性CD4 T细胞反应的灵敏方法。

Front Immunol. 2017 Oct 24;8:1370. doi: 10.3389/fimmu.2017.01370. eCollection 2017.

A Novel Approach to Reinstating Tolerance in Experimental Autoimmune Myasthenia Gravis Using a Targeted Fusion Protein, mCTA1-T146.一种使用靶向融合蛋白mCTA1-T146恢复实验性自身免疫性重症肌无力耐受性的新方法。

Front Immunol. 2017 Sep 13;8:1133. doi: 10.3389/fimmu.2017.01133. eCollection 2017.

IDO1 and TGF-β Mediate Protective Effects of IFN-α in Antigen-Induced Arthritis.吲哚胺 2,3-双加氧酶 1（IDO1）和转化生长因子-β（TGF-β）介导干扰素-α（IFN-α）在抗原诱导性关节炎中的保护作用。

J Immunol. 2016 Oct 15;197(8):3142-3151. doi: 10.4049/jimmunol.1502125. Epub 2016 Sep 19.

Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.格雷夫斯病和眼眶病小鼠模型综述——通过诱导耐受进行的新治疗

Clin Rev Allergy Immunol. 2017 Apr;52(2):182-193. doi: 10.1007/s12016-016-8562-7.

Immune interventions to preserve β cell function in type 1 diabetes.在1型糖尿病中保留β细胞功能的免疫干预措施。

J Investig Med. 2016 Jan;64(1):7-13. doi: 10.1097/JIM.0000000000000227.

本文引用的文献

Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes.质粒编码的胰岛素原在保留 C 肽的同时，特异性减少 1 型糖尿病中胰岛素原特异性 CD8⁺ T 细胞。

Sci Transl Med. 2013 Jun 26;5(191):191ra82. doi: 10.1126/scitranslmed.3006103.

Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis.自体髓鞘肽耦联细胞诱导的抗原特异性耐受：多发性硬化的 1 期临床试验。

Sci Transl Med. 2013 Jun 5;5(188):188ra75. doi: 10.1126/scitranslmed.3006168.

Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.载有致脑炎肽的微粒可诱导 T 细胞耐受并改善实验性自身免疫性脑脊髓炎。

Nat Biotechnol. 2012 Dec;30(12):1217-24. doi: 10.1038/nbt.2434. Epub 2012 Nov 18.

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.一项评估 MBP8298 在继发进展型多发性硬化症中的疗效和安全性的 III 期研究。

Neurology. 2011 Oct 18;77(16):1551-60. doi: 10.1212/WNL.0b013e318233b240. Epub 2011 Oct 5.

Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.凋亡抗原耦联白细胞诱导的耐受是由 PD-L1+和产生 IL-10 的脾巨噬细胞诱导的，并由 T 调节细胞维持。

J Immunol. 2011 Sep 1;187(5):2405-17. doi: 10.4049/jimmunol.1004175. Epub 2011 Aug 5.

Immune regulation of multiple sclerosis by transdermally applied myelin peptides.经皮给予髓鞘肽对多发性硬化症的免疫调节作用。

Ann Neurol. 2010 Nov;68(5):593-601. doi: 10.1002/ana.22219.

Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.通过抗原诱导分泌白细胞介素-10的Th1细胞分化对自身免疫反应进行负反馈控制。

J Exp Med. 2009 Aug 3;206(8):1755-67. doi: 10.1084/jem.20082118. Epub 2009 Jul 27.

Improved efficacy of a tolerizing DNA vaccine for reversal of hyperglycemia through enhancement of gene expression and localization to intracellular sites.一种耐受性DNA疫苗通过增强基因表达和定位于细胞内位点来逆转高血糖，其疗效得到改善。

J Immunol. 2008 Dec 15;181(12):8298-307. doi: 10.4049/jimmunol.181.12.8298.

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.抗CD28单克隆抗体TGN1412 1期试验中的细胞因子风暴

N Engl J Med. 2006 Sep 7;355(10):1018-28. doi: 10.1056/NEJMoa063842. Epub 2006 Aug 14.

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.髓鞘碱性蛋白肽（氨基酸83 - 99）在多发性硬化症中的致脑炎性潜能：一项使用改变肽配体的II期临床试验结果

Nat Med. 2000 Oct;6(10):1167-75. doi: 10.1038/80516.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验